首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

市場調查報告書

商品編碼

1409907

藥物臨床試驗服務市場：2024-2034

Pharma Clinical Trial Services Market Report 2024-2034

出版日期: 2024年01月09日 | 出版商:

Visiongain Reports Ltd. | 英文 263 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2034 年，全球藥物臨床試驗服務市場規模將以 8.6% 的複合年增長率成長。

臨床試驗外包顯著推動了臨床試驗服務市場的成長。製藥公司和合約研究組織 (CRO) 越來越依賴專業服務提供者來管理臨床試驗的多個方面，從患者招募到監管合規性。這一趨勢也受到外包具有吸引力的成本節約優勢的推動，外包避免了與建立內部系統相關的高成本。

本報告調查了全球藥物臨床試驗服務市場，並提供了市場概況、影響市場成長和市場機會的因素分析、市場規模趨勢和預測、各個細分市場和地區的詳細分析、競爭狀況，我們編制了主要公司的概況。

競爭環境
戰略視角
IQVIA Inc.
Syneos Health
Laboratory Corporation of America Holdings
Thermo Fisher Scientific Inc.
ICON plc
Charles River Laboratories
Eurofins Scientific
WuXi Biologics
Caidya
Calyx
Parexel International (MA) Corporation
BioPharma Services Inc.
PHARMExcel
PCI Pharma Services
Precision Medicine Group, LLC

第 14 章一般評論/建議

Visiongain 的一般討論
對參與企業的建議

簡介目錄圖表

Product Code: PHA1309

The global Pharma Clinical Trial Services market is projected to grow at a CAGR of 8.6% by 2034.

“The Pharma Clinical Trial Services Market Report 2024-2034”: This report is essential for prominent enterprises seeking fresh revenue opportunities, aiming to enhance their comprehension of the industry and its inherent dynamics. It provides valuable insights for firms interested in diversifying across various sectors or expanding their current activities into new geographical areas.

The Strategic Shift Towards Outsourcing in Clinical Trials Services to Drive the Market

The growth of the clinical trials services market is significantly propelled by the outsourcing of clinical trials activities. Pharmaceutical companies and contract research organizations (CROs) are increasingly relying on specialized service providers to manage diverse aspects of clinical trials, from patient recruitment to regulatory compliance. This trend is fuelled by the compelling benefits of cost reduction, as outsourcing avoids the high expenses associated with establishing in-house capabilities.

Moreover, access to specialized expertise enhances the quality and efficiency of trials, while established networks expedite recruitment and streamline data processes, ultimately leading to faster trial execution. As exemplified by partnerships such as, in May 2023, Thermo Fisher, a leading global provider of scientific solutions, has established a Memorandum of Understanding (MOU) with Indonesia's National Research and Innovation Agency (BRIN, Badan Riset dan Inovasi Nasional). The objective of this agreement is to enhance and bolster Indonesia's research and innovation infrastructure and capabilities, creating opportunities for extensive collaboration at the senior levels of both entities. This partnership is designed to fortify the relationship between Thermo Fisher and BRIN, promoting direct engagement and mutual advantages. In March 2023, LEO Pharma (India) and ICON plc (Ireland) have revealed a strategic collaboration with the objective of improving the execution of clinical trials. The focus of this partnership is on implementing patient-centric and cost-effective approaches, in line with LEO Pharma's overarching objective to establish a clinical portfolio execution organization that is highly efficient and effective within the medical dermatology sector.

Transformative Strategies in Biopharma: Harnessing AI and Real-World Data for Clinical Trial Innovation and Services

Biopharma companies are actively employing diverse strategies to innovate clinical trials, relying on a growing volume of scientific and research data derived from various sources, including current and past clinical trials, patient support programs, and post-market surveillance. Artificial intelligence (AI) holds the potential to contribute significantly to rational drug design, aid in decision-making processes, determine optimal treatment paths for individual patients, including tailored medications, oversee the management of generated clinical data, and facilitate its utilization in subsequent drug development. It is foreseeable that AI will play a prominent role in advancing pharmaceutical product development from the initial research phase to practical applications for patients. During the research stage of drug research and development (R&D), the primary objective is to swiftly generate a substantial number of high-quality drug candidates with the greatest likelihood of progressing to the clinical development phase. Employing AI can streamline this process by assisting in the identification of the most promising drugs and targets across all stages of the value chain. This approach enables the execution of fewer but more impactful laboratory trials, maintaining the same level of lead generation efficiency

In March 2023, Exscientia PLC announced collaboration with Charite - Universitatsmedizin Berlin (Germany) to adopt AI-driven precision medicine platform in haematological cancer trials
In January 2023, Microsoft signed its first AI partnership in Vietnam with VinBrain. The partnership aims to work on three arenas of AI healthcare: clinical trial activities, cross-product validation, and data sharing
In November 2022, Insilico Medicine entered into a multiyear, multi-target strategic research partnership with Sanofi. Under the terms of the agreement, the collaboration will leverage Pharma.AI, an AI platform developed by Insilico Medicine, to propel the development of drug candidates for up to six additional targets
In July 2022, Microsoft Azure established a partnership with the National Institutes of Health (NIH) to bolster its biomedical research initiatives. Additionally, AWS and Google Cloud have also extended their AI capabilities to support NIH in its research endeavors.

What Questions Should You Ask before Buying a Market Research Report?

How is the Pharma Clinical Trial Services market evolving?
What is driving and restraining the Pharma Clinical Trial Services market?
How will each Pharma Clinical Trial Services submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
How will the market shares for each Pharma Clinical Trial Services submarket develop from 2024 to 2034?
What will be the main driver for the overall market from 2024 to 2034?
Will leading Pharma Clinical Trial Services markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
Who are the leading players and what are their prospects over the forecast period?
What are the Pharma Clinical Trial Services projects for these leading companies?
How will the industry evolve during the period between 2024 and 2034? What are the implications of Pharma Clinical Trial Services projects taking place now and over the next 10 years?
Is there a greater need for product commercialisation to further scale the Pharma Clinical Trial Services market?
Where is the Pharma Clinical Trial Services market heading and how can you ensure you are at the forefront of the market?
What are the best investment options for new product and service lines?
What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Pharma Clinical Trial Services market today, and over the next 10 years:

Our 263-page report provides 105 tables and 142 charts/graphs exclusively to you
The report highlights key lucrative areas in the industry so you can target them - NOW
It contains in-depth analysis of global, regional and national sales and growth
It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Pharma Clinical Trial Services market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares
You will find original analyses, with business outlooks and developments
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Pharma Clinical Trial Services prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Phase

Phase I
Phase II
Phase III
Phase IV

Service Type

Clinical Trial Management
Clinical Development Strategy and Design
Sample Management
Biostatistics and Support Services

Therapeutics

Cancer
Cardiovascular
CNS
Infectious Diseases
Metabolic Diseases
Other Diseases

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

U.S
Canada

Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia Pacific

China
Japan
India
Australia
South Korea
Rest of Asia Pacific

Latin America

Brazil
Mexico
Rest of Latin America

MEA

GCC
South Africa
Rest of MEA

The report also includes profiles and for some of the leading companies in the Pharma Clinical Trial Services Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report:

BioPharma Services Inc.
Caidya
Calyx
Charles River Laboratories
Eurofins Scientific
ICON plc
IQVIA Inc.
Laboratory Corporation of America Holdings

Parexel International (MA) Corporation
PCI Pharma Services
PHARMExcel
Precision Medicine Group, LLC
Syneos Health
Thermo Fisher Scientific Inc.
WuXi Biologics

Overall world revenue for Pharma Clinical Trial Services Market, 2024 to 2034 in terms of value the market will surpass US$43 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the “Pharma Clinical Trial Services Market, 2024 to 2034” report help you?

In summary, our 260+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Pharma Clinical Trial Services Market, 2024 to 2034 Market, with forecasts for type and therapeutics each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the Pharma Clinical Trial Services Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Pharma Clinical Trial Services Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Pharma Clinical Trial Services Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

1 Report Overview

1.1 Objectives of the Study
1.2 Introduction to Pharma Clinical Trial Services Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
  - 1.7.3.1 Primary Research
  - 1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview

3.1 Key Findings
3.2 Market Dynamics
- 3.2.1 Market Driving Factors
  - 3.2.1.1 Transformative Strategies in Biopharma: Harnessing AI and Real-World Data for Clinical Trial Innovation and Services
  - 3.2.1.2 Cancer Therapeutics to Create Huge Market Scope for Clinical Trials
  - 3.2.1.3 The Strategic Shift Towards Outsourcing in Clinical Trials Services
  - 3.2.1.4 Driving Innovation: Pharma Companies Invest in R&D to Boost Clinical Trial Services Market
  - 3.2.1.5 Global Expansion of Clinical Trials Expected to Drive Industry Growth
- 3.2.2 Market Restraining Factors
  - 3.2.2.1 Navigating Challenges: Interoperability in the Clinical Trial Services Market
  - 3.2.2.2 Challenges in Patient Recruitment and Retention for Clinical Trial Service Providers
- 3.2.3 Market Opportunities
  - 3.2.3.1 Unlocking Opportunities: Pharmaceutical Companies Embrace Asia's Potential
  - 3.2.3.2 Emergence of Decentralized Clinical Trials
  - 3.2.3.3 Exploiting Opportunities Post Patent Expiry: A Boost for Clinical Trials
  - 3.2.3.4 Precision Medicine and Biomarker Trials: Catalysts for Advancing the Clinical Trial Service Market
3.3 COVID-19 Impact Analysis
3.4 Porter's Five Forces Analysis
- 3.4.1 Bargaining Power of Suppliers
- 3.4.2 Bargaining Power of Buyers
- 3.4.3 Competitive Rivalry
- 3.4.4 Threat from Substitutes
- 3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Pharma Clinical Trial Services Market Analysis by Phase

4.1 Key Findings
4.2 Phase Segment: Market Attractiveness Index
4.3 Pharma Clinical Trial Services Market Size Estimation and Forecast by Phase
4.4 Phase I
- 4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
- 4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Phase II
- 4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
- 4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Phase III
- 4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
- 4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Phase IV
- 4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
- 4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Pharma Clinical Trial Services Market Analysis by Service Type

5.1 Key Findings
5.2 Service Type Segment: Market Attractiveness Index
5.3 Pharma Clinical Trial Services Market Size Estimation and Forecast by Service Type
5.4 Clinical Trial Management
- 5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
- 5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Clinical Development Strategy and Design
- 5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
- 5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Sample Management
- 5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
- 5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 Biostatistics and Support Services
- 5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
- 5.7.2 Market Share by Region, 2024 & 2034 (%)

6 Pharma Clinical Trial Services Market Analysis by Therapeutics

6.1 Key Findings
6.2 Therapeutics Segment: Market Attractiveness Index
6.3 Pharma Clinical Trial Services Market Size Estimation and Forecast by Therapeutics
6.4 Cancer
- 6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
- 6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Cardiovascular
- 6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
- 6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 CNS
- 6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
- 6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Infectious Diseases
- 6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
- 6.7.2 Market Share by Region, 2024 & 2034 (%)
6.8 Metabolic Diseases
- 6.8.1 Market Size by Region, 2024-2034 (US$ Billion)
- 6.8.2 Market Share by Region, 2024 & 2034 (%)
6.9 Other Diseases
- 6.9.1 Market Size by Region, 2024-2034 (US$ Billion)
- 6.9.2 Market Share by Region, 2024 & 2034 (%)

7 Pharma Clinical Trial Services Market Analysis by Region

7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast

8 North America Pharma Clinical Trial Services Market Analysis

8.1 Key Findings
8.2 North America Pharma Clinical Trial Services Market Attractiveness Index
8.3 North America Pharma Clinical Trial Services Market by Country, 2023, 2028 & 2033 (US$ Billion)
8.4 North America Pharma Clinical Trial Services Market Size Estimation and Forecast by Country
8.5 North America Pharma Clinical Trial Services Market Size Estimation and Forecast by Phase
8.6 North America Pharma Clinical Trial Services Market Size Estimation and Forecast by Service Type
8.7 North America Pharma Clinical Trial Services Market Size Estimation and Forecast by Therapeutics
8.8 U.S. Pharma Clinical Trial Services Market Analysis
8.9 Canada Pharma Clinical Trial Services Market Analysis

9 Europe Pharma Clinical Trial Services Market Analysis

9.1 Key Findings
9.2 Europe Pharma Clinical Trial Services Market Attractiveness Index
9.3 Europe Pharma Clinical Trial Services Market by Country, 2023, 2028 & 2033 (US$ Billion)
9.4 Europe Pharma Clinical Trial Services Market Size Estimation and Forecast by Country
9.5 Europe Pharma Clinical Trial Services Market Size Estimation and Forecast by Phase
9.6 Europe Pharma Clinical Trial Services Market Size Estimation and Forecast by Service Type
9.7 Europe Pharma Clinical Trial Services Market Size Estimation and Forecast by Therapeutics
9.8 Germany Pharma Clinical Trial Services Market Analysis
9.9 France Pharma Clinical Trial Services Market Analysis
9.10 UK Pharma Clinical Trial Services Market Analysis
9.11 Italy Pharma Clinical Trial Services Market Analysis
9.12 Spain Pharma Clinical Trial Services Market Analysis
9.13 Rest of Europe Pharma Clinical Trial Services Market Analysis

10 Asia Pacific Pharma Clinical Trial Services Market Analysis

10.1 Key Findings
10.2 Asia Pacific Pharma Clinical Trial Services Market Attractiveness Index
10.3 Asia Pacific Pharma Clinical Trial Services Market by Country, 2023, 2028 & 2033 (US$ Billion)
10.4 Asia Pacific Pharma Clinical Trial Services Market Size Estimation and Forecast by Country
10.5 Asia Pacific Pharma Clinical Trial Services Market Size Estimation and Forecast by Phase
10.6 Asia Pacific Pharma Clinical Trial Services Market Size Estimation and Forecast by Service Type
10.7 Asia Pacific Pharma Clinical Trial Services Market Size Estimation and Forecast by Therapeutics
10.8 Japan Pharma Clinical Trial Services Market Analysis
10.9 China Pharma Clinical Trial Services Market Analysis
10.10 India Pharma Clinical Trial Services Market Analysis
10.11 Australia Pharma Clinical Trial Services Market Analysis
10.12 South Korea Pharma Clinical Trial Services Market Analysis
10.13 Rest of Asia Pacific Pharma Clinical Trial Services Market Analysis

11 Latin America Pharma Clinical Trial Services Market Analysis

11.1 Key Findings
11.2 Latin America Pharma Clinical Trial Services Market Attractiveness Index
11.3 Latin America Pharma Clinical Trial Services Market by Country, 2023, 2028 & 2033 (US$ Billion)
11.4 Latin America Pharma Clinical Trial Services Market Size Estimation and Forecast by Country
11.5 Latin America Pharma Clinical Trial Services Market Size Estimation and Forecast by Phase
11.6 Latin America Pharma Clinical Trial Services Market Size Estimation and Forecast by Service Type
11.7 Latin America Pharma Clinical Trial Services Market Size Estimation and Forecast by Therapeutics
11.8 Brazil Pharma Clinical Trial Services Market Analysis
11.9 Mexico Pharma Clinical Trial Services Market Analysis
11.10 Rest of Latin America Pharma Clinical Trial Services Market Analysis

12 MEA Pharma Clinical Trial Services Market Analysis

12.1 Key Findings
12.2 MEA Pharma Clinical Trial Services Market Attractiveness Index
12.3 MEA Pharma Clinical Trial Services Market by Country, 2023, 2028 & 2033 (US$ Billion)
12.4 MEA Pharma Clinical Trial Services Market Size Estimation and Forecast by Country
12.5 MEA Pharma Clinical Trial Services Market Size Estimation and Forecast by Phase
12.6 MEA Pharma Clinical Trial Services Market Size Estimation and Forecast by Service Type
12.7 MEA Pharma Clinical Trial Services Market Size Estimation and Forecast by Therapeutics
12.8 GCC Pharma Clinical Trial Services Market Analysis
12.9 South Africa Pharma Clinical Trial Services Market Analysis
12.10 Rest of MEA Pharma Clinical Trial Services Market Analysis

13 Company Profiles

13.1 Competitive Landscape, 2022
13.2 Strategic Outlook
13.3 IQVIA Inc.
- 13.3.1 Company Snapshot
- 13.3.2 Company Overview
- 13.3.3 Financial Analysis
  - 13.3.3.1 Net Revenue, 2017-2022
  - 13.3.3.2 Regional Market Shares, 2022
- 13.3.4 Services Benchmarking
- 13.3.5 Strategic Outlook
13.4 Syneos Health
- 13.4.1 Company Snapshot
- 13.4.2 Company Overview
- 13.4.3 Financial Analysis
  - 13.4.3.1 Net Revenue, 2017-2022
  - 13.4.3.2 Regional Market Shares, 2022
- 13.4.4 Services Benchmarking
- 13.4.5 Strategic Outlook
13.5 Laboratory Corporation of America Holdings
- 13.5.1 Company Snapshot
- 13.5.2 Company Overview
- 13.5.3 Financial Analysis
  - 13.5.3.1 Net Revenue, 2017-2022
- 13.5.4 Services Benchmarking
- 13.5.5 Strategic Outlook
13.6 Thermo Fisher Scientific Inc.
- 13.6.1 Company Snapshot
- 13.6.2 Company Overview
- 13.6.3 Financial Analysis
  - 13.6.3.1 Net Revenue, 2017-2022
  - 13.6.3.2 R&D, 2017-2022
  - 13.6.3.3 Regional Market Shares, 2022
- 13.6.4 Services Benchmarking
- 13.6.5 Strategic Outlook
13.7 ICON plc
- 13.7.1 Company Snapshot
- 13.7.2 Company Overview
- 13.7.3 Financial Analysis
  - 13.7.3.1 Net Revenue, 2017-2022
  - 13.7.3.2 Regional Market Shares, 2022
- 13.7.4 Services Benchmarking
- 13.7.5 Strategic Outlook
13.8 Charles River Laboratories
- 13.8.1 Company Snapshot
- 13.8.2 Company Overview
- 13.8.3 Financial Analysis
  - 13.8.3.1 Net Revenue, 2017-2022
- 13.8.4 Services Benchmarking
- 13.8.5 Strategic Outlook
13.9 Eurofins Scientific
- 13.9.1 Company Snapshot
- 13.9.2 Company Overview
- 13.9.3 Financial Analysis
  - 13.9.3.1 Net Revenue, 2017-2022
  - 13.9.3.2 Regional Market Shares, 2022
- 13.9.4 Services Benchmarking
- 13.9.5 Strategic Outlook
13.10 WuXi Biologics
- 13.10.1 Company Snapshot
- 13.10.2 Company Overview
- 13.10.3 Financial Analysis
  - 13.10.3.1 Net Revenue, 2018-2022
  - 13.10.3.2 R&D, 2018-2022
  - 13.10.3.3 Regional Market Shares, 2022
- 13.10.4 Services Benchmarking
13.11 Caidya
- 13.11.1 Company Snapshot
- 13.11.2 Company Overview
- 13.11.3 Services Benchmarking
13.12 Calyx
- 13.12.1 Company Snapshot
- 13.12.2 Company Overview
- 13.12.3 Services Benchmarking
- 13.12.4 Strategic Outlook
13.13 Parexel International (MA) Corporation
- 13.13.1 Company Snapshot
- 13.13.2 Company Overview
- 13.13.3 Services Benchmarking
- 13.13.4 Strategic Outlook
13.14 BioPharma Services Inc.
- 13.14.1 Company Snapshot
- 13.14.2 Company Overview
- 13.14.3 Services Benchmarking
- 13.14.4 Strategic Outlook
13.15 PHARMExcel
- 13.15.1 Company Snapshot
- 13.15.2 Company Overview
- 13.15.3 Services Benchmarking
13.16 PCI Pharma Services
- 13.16.1 Company Snapshot
- 13.16.2 Company Overview
- 13.16.3 Services Benchmarking
13.17 Precision Medicine Group, LLC
- 13.17.1 Company Snapshot
- 13.17.2 Company Overview
- 13.17.3 Services Benchmarking
- 13.17.4 Strategic Outlook

14 Conclusion and Recommendations

14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players

簡介目錄圖表

List of Tables

Table 1 Pharma Clinical Trial Services Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Pharma Clinical Trial Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Pharma Clinical Trial Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Pharma Clinical Trial Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Pharma Clinical Trial Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 7 Phase I Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 8 Phase II Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 9 Phase III Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Phase IV Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Clinical Trial Management Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Clinical Development Strategy and Design Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Sample Management Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Biostatistics and Support Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 16 Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 17 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 18 Cardiovascular Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 CNS Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Metabolic Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Other Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Pharma Clinical Trial Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 North America Pharma Clinical Trial Services Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 North America Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 28 U.S. Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 29 Canada Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 Europe Pharma Clinical Trial Services Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 31 Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 32 Europe Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 34 Germany Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 35 France Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 36 UK Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 37 Italy Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 Spain Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 Rest of Europe Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 Asia Pacific Pharma Clinical Trial Services Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Asia Pacific Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 44 Japan Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 China Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 India Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 47 Australia Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 48 South Korea Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 Rest of Asia Pacific Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 50 Latin America Pharma Clinical Trial Services Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 51 Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Latin America Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 54 Brazil Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Mexico Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Rest of Latin America Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 57 MEA Pharma Clinical Trial Services Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 58 Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 59 MEA Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 61 GCC Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 South Africa Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 63 Rest of MEA Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 Strategic Outlook
Table 65 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 IQVIA Inc.: Services Benchmarking
Table 67 IQVIA Inc.: Strategic Outlook
Table 68 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 Syneos Health: Services Benchmarking
Table 70 Syneos Health: Strategic Outlook
Table 71 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Laboratory Corporation of America Holdings: Services Benchmarking
Table 73 Laboratory Corporation of America Holdings: Strategic Outlook
Table 74 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Thermo Fisher Scientific Inc.: Services Benchmarking
Table 76 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 77 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 ICON plc: Services Benchmarking
Table 79 ICON plc: Strategic Outlook
Table 80 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Charles River Laboratories: Services Benchmarking
Table 82 Charles River Laboratories: Strategic Outlook
Table 83 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Eurofins Scientific: Services Benchmarking
Table 85 Eurofins Scientific: Strategic Outlook
Table 86 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 WuXi Biologics: Services Benchmarking
Table 88 Caidya: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Caidya: Services Benchmarking
Table 90 Calyx: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Calyx: Services Benchmarking
Table 92 Calyx: Strategic Outlook
Table 93 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Parexel International (MA) Corporation: Services Benchmarking
Table 95 Parexel International (MA) Corporation: Strategic Outlook
Table 96 BioPharma Services Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 BioPharma Services Inc.: Services Benchmarking
Table 98 BioPharma Services Inc.: Strategic Outlook
Table 99 PHARMExcel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 PHARMExcel: Services Benchmarking
Table 101 PCI Pharma Services: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 PCI Pharma Services: Services Benchmarking
Table 103 Precision Medicine Group, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Precision Medicine Group, LLC: Services Benchmarking
Table 105 Precision Medicine Group, LLC: Strategic Outlook

List of Figures

Figure 1 Pharma Clinical Trial Services Market Segmentation
Figure 2 Pharma Clinical Trial Services Market by Phase: Market Attractiveness Index
Figure 3 Pharma Clinical Trial Services Market by Services Type: Market Attractiveness Index
Figure 4 Pharma Clinical Trial Services Market by Therapeutics: Market Attractiveness Index
Figure 5 Pharma Clinical Trial Services Market Attractiveness Index by Region
Figure 6 Pharma Clinical Trial Services Market: Market Dynamics
Figure 7 Cancer Case per 100,000 Population, 2015 - 2023
Figure 8 Pharma R&D Investment (US$ Billion)
Figure 9 Clinical Trials by Leading Countries, 2022
Figure 10 Pharma Clinical Trial Services Market by Region, 2024-2034 (US$ Billion, AGR %): "V" Shaped Recovery
Figure 11 Pharma Clinical Trial Services Market by Region, 2024-2034 (US$ Billion, AGR %): "U" Shaped Recovery
Figure 12 Pharma Clinical Trial Services Market by Region, 2024-2034 (US$ Billion, AGR %): "W" Shaped Recovery
Figure 13 Pharma Clinical Trial Services Market by Region, 2024-2034 (US$ Billion, AGR %): "L" Shaped Recovery
Figure 14 Pharma Clinical Trial Services Market: Porter's Five Forces Analysis
Figure 15 Pharma Clinical Trial Services Market: PEST Analysis
Figure 16 Pharma Clinical Trial Services Market by Phase: Market Attractiveness Index
Figure 17 Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
Figure 18 Pharma Clinical Trial Services Market Share Forecast by Phase, 2024, 2029, 2034 (%)
Figure 19 Phase I Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 20 Phase I Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Phase II Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 22 Phase II Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Phase III Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 24 Phase III Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Phase IV Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 26 Phase IV Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Pharma Clinical Trial Services Market by Service Type: Market Attractiveness Index
Figure 28 Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR %)
Figure 29 Pharma Clinical Trial Services Market Share Forecast by Service Type, 2024, 2029, 2034 (%)
Figure 30 Clinical Trial Management Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 31 Clinical Trial Management Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 32 Clinical Development Strategy and Design Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 33 Clinical Development Strategy and Design Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Sample Management Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 35 Sample Management Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Biostatistics and Support Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 37 Biostatistics and Support Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Pharma Clinical Trial Services Market by Therapeutics: Market Attractiveness Index
Figure 39 Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR %)
Figure 40 Pharma Clinical Trial Services Market Share Forecast by Therapeutics, 2024, 2029, 2034 (%)
Figure 41 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 42 Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Cardiovascular Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 44 Cardiovascular Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 CNS Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 46 CNS Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 47 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 48 Infectious Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 49 Metabolic Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 50 Metabolic Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 51 Other Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 52 Other Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 53 Pharma Clinical Trial Services Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
Figure 54 Pharma Clinical Trial Services Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 55 Pharma Clinical Trial Services Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 56 North America Pharma Clinical Trial Services Market Attractiveness Index
Figure 57 North America Pharma Clinical Trial Services Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 58 North America Pharma Clinical Trial Services Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 59 North America Pharma Clinical Trial Services Market Share Forecast by Country, 2024 & 2034 (%)
Figure 60 North America Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
Figure 61 North America Pharma Clinical Trial Services Market Share Forecast by Phase, 2024 & 2034 (%)
Figure 62 North America Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR %)
Figure 63 North America Pharma Clinical Trial Services Market Share Forecast by Service Type, 2024 & 2034 (%)
Figure 64 North America Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR %)
Figure 65 North America Pharma Clinical Trial Services Market Share Forecast by Therapeutics, 2024 & 2034 (%)
Figure 66 U.S. Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 67 Canada Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 68 Europe Pharma Clinical Trial Services Market Attractiveness Index
Figure 69 Europe Pharma Clinical Trial Services Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 70 Europe Pharma Clinical Trial Services Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 71 Europe Pharma Clinical Trial Services Market Share Forecast by Country, 2024 & 2034 (%)
Figure 72 Europe Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
Figure 73 Europe Pharma Clinical Trial Services Market Share Forecast by Phase, 2024 & 2034 (%)
Figure 74 Europe Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR %)
Figure 75 Europe Pharma Clinical Trial Services Market Share Forecast by Service Type, 2024 & 2034 (%)
Figure 76 Europe Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR %)
Figure 77 Europe Pharma Clinical Trial Services Market Share Forecast by Therapeutics, 2024 & 2034 (%)
Figure 78 Germany Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 79 France Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 80 UK Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 81 Italy Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 82 Spain Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 83 Rest of Europe Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 84 Asia Pacific Pharma Clinical Trial Services Market Attractiveness Index
Figure 85 Asia Pacific Pharma Clinical Trial Services Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 86 Asia Pacific Pharma Clinical Trial Services Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 87 Asia Pacific Pharma Clinical Trial Services Market Share Forecast by Country, 2024 & 2034 (%)
Figure 88 Asia Pacific Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
Figure 89 Asia Pacific Pharma Clinical Trial Services Market Share Forecast by Phase, 2024 & 2034 (%)
Figure 90 Asia Pacific Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR %)
Figure 91 Asia Pacific Pharma Clinical Trial Services Market Share Forecast by Service Type, 2024 & 2034 (%)
Figure 92 Asia Pacific Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR %)
Figure 93 Asia Pacific Pharma Clinical Trial Services Market Share Forecast by Therapeutics, 2024 & 2034 (%)
Figure 94 Japan Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 95 China Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 96 India Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 97 Australia Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 98 South Korea Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 99 Rest of Asia Pacific Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 100 Latin America Pharma Clinical Trial Services Market Attractiveness Index
Figure 101 Latin America Pharma Clinical Trial Services Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 102 Latin America Pharma Clinical Trial Services Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 103 Latin America Pharma Clinical Trial Services Market Share Forecast by Country, 2024 & 2034 (%)
Figure 104 Latin America Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
Figure 105 Latin America Pharma Clinical Trial Services Market Share Forecast by Phase, 2024 & 2034 (%)
Figure 106 Latin America Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR %)
Figure 107 Latin America Pharma Clinical Trial Services Market Share Forecast by Service Type, 2024 & 2034 (%)
Figure 108 Latin America Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR %)
Figure 109 Latin America Pharma Clinical Trial Services Market Share Forecast by Therapeutics, 2024 & 2034 (%)
Figure 110 Brazil Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 111 Mexico Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 112 Rest of Latin America Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 113 MEA Pharma Clinical Trial Services Market Attractiveness Index
Figure 114 MEA Pharma Clinical Trial Services Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 115 MEA Pharma Clinical Trial Services Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 116 MEA Pharma Clinical Trial Services Market Share Forecast by Country, 2024 & 2034 (%)
Figure 117 MEA Pharma Clinical Trial Services Market Forecast by Phase, 2024-2034 (US$ Billion, AGR %)
Figure 118 MEA Pharma Clinical Trial Services Market Share Forecast by Phase, 2024 & 2034 (%)
Figure 119 MEA Pharma Clinical Trial Services Market Forecast by Service Type, 2024-2034 (US$ Billion, AGR %)
Figure 120 MEA Pharma Clinical Trial Services Market Share Forecast by Service Type, 2024 & 2034 (%)
Figure 121 MEA Pharma Clinical Trial Services Market Forecast by Therapeutics, 2024-2034 (US$ Billion, AGR %)
Figure 122 MEA Pharma Clinical Trial Services Market Share Forecast by Therapeutics, 2024 & 2034 (%)
Figure 123 GCC Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 124 South Africa Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 125 Rest of MEA Pharma Clinical Trial Services Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 126 IQVIA Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 127 IQVIA Inc.: Regional Market Shares, 2022
Figure 128 Syneos Health: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 129 Syneos Health: Regional Market Shares, 2022
Figure 130 Laboratory Corporation of America Holdings: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 131 Thermo Fisher Scientific Inc.: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 132 Thermo Fisher Scientific Inc.: R&D, 2017-2022 (US$ Billion, AGR%)
Figure 133 Thermo Fisher Scientific Inc.: Regional Market Shares, 2022
Figure 134 ICON plc: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 135 ICON plc: Regional Market Shares, 2022
Figure 136 Charles River Laboratories: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 137 Eurofins Scientific: Net Revenue, 2017-2022 (US$ Billion, AGR%)
Figure 138 Eurofins Scientific: Regional Market Shares, 2022
Figure 139 WuXi Biologics: Net Revenue, 2018-2022 (US$ Billion, AGR%)
Figure 140 WuXi Biologics: R&D, 2018-2022 (US$ Billion, AGR%)
Figure 141 WuXi Biologics: Regional Market Shares, 2022